Richard Buchholz - Feb 9, 2024 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Role
Chief Financial Officer
Signature
/s/ Bryan Phillips, Attorney-in-Fact for Richard Buchholz
Stock symbol
INSP
Transactions as of
Feb 9, 2024
Transactions value $
$0
Form type
4
Date filed
2/13/2024, 09:39 PM
Previous filing
Feb 14, 2023
Next filing
Apr 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSP Common Stock Award $0 +2.69K +6.64% $0.00 43.3K Feb 9, 2024 Direct F1, F2
holding INSP Common Stock 1.23K Feb 9, 2024 By daughter
holding INSP Common Stock 1.23K Feb 9, 2024 By son
holding INSP Common Stock 1.23K Feb 9, 2024 By son
holding INSP Common Stock 1.23K Feb 9, 2024 By son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INSP Employee Stock Option (Right to Buy) Award $0 +4.38K $0.00 4.38K Feb 9, 2024 Common Stock 4.38K $194.87 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 9, 2025. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.
F2 Includes (i) 58 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2023 and (ii) 32 shares acquired under the Plan on December 31, 2023.
F3 The option vests and becomes exercisable as to 25% of the underlying shares on February 9, 2025. The remaining 75% of the underlying shares will vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.